December 6th 2024
Lilly is investing $3 billion to expand its recently acquired manufacturing facility in Wisconsin, while Amgen is investing $1 billion to expand its facility in North Carolina.
FDA and EMA Accept Biologics Application for Novartis Multiple Sclerosis Cell Therapy
February 27th 2020If approved, the therapy may become the first-choice treatment for relapsing multiple sclerosis patients and will be the first B-cell therapy that can be self-administered using an autoinjector pen.